6,543 followers
New research: The role of daratumumab in relapsed/refractory CD38 positive acute leukemias—case report on three cases with a literature review: Primary refractory or relapsed T-cell acute lymphoblastic leukemia (T-ALL) and mixed phenotype… https://t.co/xDy